Author:
Piccart M.J.,Stuart G.C.E.,Cassidy J.,Bertelsen K.,Parmar M.K.B.,Eisenhauer E.A.,Kaye S.B.,Tropé C.,Swenerton K.,Harper P.,Vermorken J.B.
Reference10 articles.
1. Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis;J Clin Oncol,1991
2. Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma;Fanning;Obstet Gynecol,1992
3. Impact of doxorubicin on survival in advanced ovarian cancer;A’Hern;J Clin Oncol,1995
4. Meta-analyses of chemotherapy regimens for ovarian carcinoma : a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide;West;Eur J Gynaec Oncol,1997
5. Chemotherapy in advanced ovarian cancer : An overview of randomized clinical trials;Br Med J,1991
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献